Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes

Lancet. 2014 Sep 20;384(9948):1095. doi: 10.1016/S0140-6736(14)61671-8.

Authors

John S Yudkin¹, Sandeep Vijan², Jeremy B Sussman², Richard Lehman³, Ben M Goldacre⁴

Affiliations

¹ Division of Medicine, University College, London WC1E 6BT, UK. Electronic address: j.yudkin@ucl.ac.uk.
² Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
³ Department of Primary Health Care, University of Oxford, Oxford, UK.
⁴ London School of Hygiene & Tropical Medicine, London, UK.

PMID: 25241716
DOI: 10.1016/S0140-6736(14)61671-8

No abstract available

Publication types

Letter
Comment

MeSH terms

Diabetes Mellitus, Type 2 / drug therapy*
Diabetic Angiopathies / drug therapy*
Humans
Hypoglycemic Agents / therapeutic use*

Substances

Hypoglycemic Agents